Literature DB >> 19386538

Vibrational spectroscopic studies and DFT calculations of 4-aminoantipyrine.

J Swaminathan1, M Ramalingam, V Sethuraman, N Sundaraganesan, S Sebastian.   

Abstract

The pyrazole derivative, 4-aminoantipyrine (4AAP), used as an intermediate for the synthesis of pharmaceuticals especially antipyretic and analgesic drugs has been analyzed experimentally and theoretically for its vibrational frequencies. The FTIR and FT Raman spectra of the title compound have been compared with the theoretically computed frequencies invoking the standard 6-311g(d,p) and cc-pVDZ basis sets at DFT level of theory (B3LYP). The harmonic vibrational frequencies at B3LYP/cc-pVDZ after appropriate scaling method seem to coincide satisfactorily with the experimental observations rather than B3LYP/6-311g(d,p) results. The theoretical spectrograms for FT-IR and FT-Raman spectra of 4AAP have been also constructed and compared with the experimental spectra. Additionally, thermodynamic data have also been calculated and discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386538     DOI: 10.1016/j.saa.2009.03.009

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Comprehensive spectral identification of key intermediates to the final product of the chiral pool synthesis of radezolid.

Authors:  Katarzyna Michalska; Elżbieta Bednarek; Ewa Gruba; Kornelia Lewandowska; Mikołaj Mizera; Judyta Cielecka-Piontek
Journal:  Chem Cent J       Date:  2017-08-09       Impact factor: 4.215

2.  Theoretical Investigation on the ESIPT Process and Detection Mechanism for Dual-Proton Type Fluorescent Probe.

Authors:  Yunjian Cao; Xiangrui Yu; Chaofan Sun; Jingang Cui
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

3.  CREBH determines the severity of sulpyrine-induced fatal shock.

Authors:  Naganori Kamiyama; Masahiro Yamamoto; Hiroyuki Saiga; Ji Su Ma; Jun Ohshima; Sakaaki Machimura; Miwa Sasai; Taishi Kimura; Yoshiyasu Ueda; Hisako Kayama; Kiyoshi Takeda
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.